# Ensysce Biosciences Inc. (ENSC) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$10M |
| 2024 | -$7M |
| 2023 | -$11M |
| 2022 | -$24M |
| 2021 | -$20M |
| 2020 | -$2M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$4M |
| 2025-09-30 | -$4M |
| 2025-06-30 | -$2M |
| 2025-03-31 | -$2M |
| 2024-09-30 | $644,746 |
| 2024-06-30 | -$2M |
| 2024-03-31 | -$2M |
| 2023-09-30 | -$3M |
| 2023-06-30 | -$2M |
| 2023-03-31 | -$3M |
| 2022-09-30 | -$6M |
| 2022-06-30 | -$7M |
| 2022-03-31 | -$5M |
| 2021-09-30 | -$17M |
| 2021-06-30 | -$412,617 |
| 2021-03-31 | -$524,273 |
| 2020-09-30 | -$404,774 |
| 2020-06-30 | $139,081 |

Source: [CompaniesByCap](https://companiesbycap.com/company/ENSC/operating-income)